Junli Hao

716 total citations
26 papers, 572 citations indexed

About

Junli Hao is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Junli Hao has authored 26 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Cancer Research and 5 papers in Epidemiology. Recurrent topics in Junli Hao's work include MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (4 papers). Junli Hao is often cited by papers focused on MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (4 papers). Junli Hao collaborates with scholars based in China, Australia and Hong Kong. Junli Hao's co-authors include Changfei Li, Songdong Meng, Saifeng Wang, Jun Hu, Yaxing Xu, Lizhao Chen, Ying Ju, Hongxia Fan, Bo Wu and Xiaoyu Chu and has published in prestigious journals such as Journal of Virology, Scientific Reports and Food Research International.

In The Last Decade

Junli Hao

24 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junli Hao China 10 350 306 173 130 45 26 572
Henghui Zhang China 11 224 0.6× 194 0.6× 45 0.3× 70 0.5× 43 1.0× 28 476
Shu Feng China 12 131 0.4× 89 0.3× 189 1.1× 146 1.1× 24 0.5× 26 374
Bahaeldin K. Elamin Sudan 11 323 0.9× 271 0.9× 65 0.4× 37 0.3× 27 0.6× 15 495
Guo‐qiang Lou China 12 178 0.5× 81 0.3× 225 1.3× 123 0.9× 23 0.5× 30 463
Yaming Li China 12 225 0.6× 106 0.3× 106 0.6× 68 0.5× 136 3.0× 21 533
Xinqiang Xiao China 11 140 0.4× 85 0.3× 109 0.6× 75 0.6× 34 0.8× 25 293
Mai Hong Bang Vietnam 11 136 0.4× 78 0.3× 132 0.8× 123 0.9× 30 0.7× 25 377
Yuqiang Niu China 10 190 0.5× 116 0.4× 106 0.6× 72 0.6× 74 1.6× 15 412
Liping Liu China 12 165 0.5× 57 0.2× 132 0.8× 72 0.6× 28 0.6× 33 468
Mona Zoheiry Egypt 12 144 0.4× 104 0.3× 75 0.4× 69 0.5× 22 0.5× 22 339

Countries citing papers authored by Junli Hao

Since Specialization
Citations

This map shows the geographic impact of Junli Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junli Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junli Hao more than expected).

Fields of papers citing papers by Junli Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junli Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junli Hao. The network helps show where Junli Hao may publish in the future.

Co-authorship network of co-authors of Junli Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Junli Hao. A scholar is included among the top collaborators of Junli Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junli Hao. Junli Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xitao, Hongwei Deng, Yapeng Lin, et al.. (2025). Potential Function of Glycosylated RNA in Diseases. Wiley Interdisciplinary Reviews - RNA. 16(6). e70031–e70031.
2.
Wang, Guanghong, Siwei Deng, Yu Chi Yang, et al.. (2024). Tibetan tea extract exerts anti-tumor effects and potentiate paclitaxel-induced cytotoxicity and apoptosis in human hepatocellular carcinoma cells HepG2. South African Journal of Botany. 173. 380–387. 1 indexed citations
3.
Chen, Kejie, Hang Cheng, Min Yang, et al.. (2024). Identification and characterization of extrachromosomal circular DNA in large‐artery atherosclerotic stroke. Journal of Cellular and Molecular Medicine. 28(7). e18210–e18210. 3 indexed citations
4.
Yang, Le, Danni Zheng, Yapeng Lin, et al.. (2024). METTL3-mediated methylation of CYP2C19 mRNA may aggravate clopidogrel resistance in ischemic stroke patients. Open Medicine. 19(1). 20240899–20240899.
5.
Zhang, Siyu, Junli Hao, Qinggang Xie, et al.. (2023). pH-induced physiochemical and structural changes of milk proteins mixtures and its effect on foaming behavior. International Journal of Biological Macromolecules. 254(Pt 2). 127838–127838. 20 indexed citations
6.
Chen, Xiaoling, et al.. (2023). CircRNA and Stroke: New Insight of Potential Biomarkers and Therapeutic Targets. Neurochemical Research. 49(3). 557–567. 5 indexed citations
7.
Yang, Min, Junli Hao, Kejie Chen, et al.. (2023). Lower Plasma miR-223 Level Is Associated with Clopidogrel Resistance in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis. Journal of Interventional Cardiology. 2023. 1–6. 1 indexed citations
8.
Lin, Yapeng, et al.. (2023). Ticagrelor Resistance in Cardiovascular Disease and Ischemic Stroke. Journal of Clinical Medicine. 12(3). 1149–1149. 6 indexed citations
9.
Tan, Yixuan, Junli Hao, Yuhang Jiang, et al.. (2023). Effects of Different Thermal Treatments on Structural and Physicochemical Properties of Model Infant Formula. SSRN Electronic Journal. 1 indexed citations
10.
Hao, Junli, et al.. (2023). Lipidomics of Sannen goat milk subjected to pasteurization and spray drying based on LC-ESI-MS/MS. Food Research International. 169. 112841–112841. 4 indexed citations
11.
Yang, Jie, Junli Hao, Yapeng Lin, et al.. (2022). Profile and Functional Prediction of Plasma Exosome-Derived CircRNAs From Acute Ischemic Stroke Patients. Frontiers in Genetics. 13. 810974–810974. 14 indexed citations
12.
Leng, Xinyi, Danni Zheng, Junli Hao, et al.. (2022). The Mechanism and Role of N6-Methyladenosine (m6A) Modification in Atherosclerosis and Atherosclerotic Diseases. Journal of Cardiovascular Development and Disease. 9(11). 367–367. 4 indexed citations
13.
Yang, Jie, Hong Xu, Kejie Chen, et al.. (2022). Platelets-Derived miR-200a-3p Modulate the Expression of ET-1 and VEGFA in Endothelial Cells by Targeting MAPK14. Frontiers in Physiology. 13. 893102–893102. 8 indexed citations
14.
Wang, Yuanyuan, Junli Hao, Xiaohong Liu, et al.. (2016). The mechanism of apoliprotein A1 down-regulated by Hepatitis B virus. Lipids in Health and Disease. 15(1). 64–64. 36 indexed citations
15.
Chu, Xiaoyu, Bo Wu, Hongxia Fan, et al.. (2016). PTD-fused p53 as a potential antiviral agent directly suppresses HBV transcription and expression. Antiviral Research. 127. 41–49. 16 indexed citations
16.
Li, Changfei, Mengmeng Deng, Jun Hu, et al.. (2016). Chronic inflammation contributes to the development of hepatocellular carcinoma by decreasing miR-122 levels. Oncotarget. 7(13). 17021–17034. 54 indexed citations
17.
Li, Changfei, Jun Hu, Junli Hao, et al.. (2014). Competitive virus and host RNAs: the interplay of a hidden virus and host interaction. Protein & Cell. 5(5). 348–356. 29 indexed citations
18.
Hu, Jun, Yaxing Xu, Junli Hao, et al.. (2012). MiR-122 in hepatic function and liver diseases. Protein & Cell. 3(5). 364–371. 172 indexed citations
19.
Li, Changfei, Yanzhong Wang, Saifeng Wang, et al.. (2012). Hepatitis B Virus mRNA-Mediated miR-122 Inhibition Upregulates PTTG1-Binding Protein, Which Promotes Hepatocellular Carcinoma Tumor Growth and Cell Invasion. Journal of Virology. 87(4). 2193–2205. 125 indexed citations
20.
Hao, Junli, Wensong Jin, Xinghui Li, et al.. (2012). Inhibition of Alpha Interferon (IFN-α)-Induced MicroRNA-122 Negatively Affects the Anti-Hepatitis B Virus Efficiency of IFN-α. Journal of Virology. 87(1). 137–147. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henghui Zhang Breakdown of academic impact, for papers by Shu Feng Breakdown of academic impact, for papers by Bahaeldin K. Elamin Breakdown of academic impact, for papers by Guo‐qiang Lou Breakdown of academic impact, for papers by Yaming Li Breakdown of academic impact, for papers by Xinqiang Xiao Breakdown of academic impact, for papers by Mai Hong Bang Breakdown of academic impact, for papers by Yuqiang Niu Breakdown of academic impact, for papers by Liping Liu Breakdown of academic impact, for papers by Mona Zoheiry
Rankless by CCL
2026